Imetit dihydrobromide is a potent and selective agonist of histamine H3 and H4 receptors (Ki = 0.3 nM and 2.7 nM, respectively); it mimics histamine-induced shape change in eosinophils (EC50 = 25 nM); it reduces apomorphine-induced licking behavior in male Sprague-Dawley rats when administered intraperitoneally at doses of 2.5–10 mg/kg.